• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度部落次区域计划地区资源有限环境下镰状细胞病即时检测的操作可行性

Operational Feasibility of Point-of-Care Testing for Sickle Cell Disease in Resource-Limited Settings of Tribal Sub-Plan Region of India.

作者信息

Thakor Mahendra, Gautam Janesh Kumar, Panigrahi Ansuman, Garasiya Dharmendra, Brhamnia Shankar Lal, Mohanty Suman Sundar

机构信息

ICMR-National Institute for Implementation Research on Non-Communicable Diseases, New Pali Road, Jodhpur 342005, India.

Office of Block Chief Medical Officer, Jhadol, Udaipur 313702, India.

出版信息

Diagnostics (Basel). 2025 Feb 2;15(3):348. doi: 10.3390/diagnostics15030348.

DOI:10.3390/diagnostics15030348
PMID:39941278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11817183/
Abstract

: Sickle cell disease (SCD) individuals in India are mostly identified when they become symptomatic. To provide a timely diagnosis of SCD to participants, healthcare workers should be competent in using the point-of-care test (POCT). In this study, we aimed to evaluate the competence of healthcare workers to screen infants and adult populations through POCT. : This study was conducted in pilot mode over 8 months from April to November 2023. A random sampling method was used to select ten auxiliary nursing midwives (ANMs), ten lab technicians (LTs), and five medical officers (MOs). Each selected ANM and LT was supposed to conduct ten tests and MOs to conduct five tests. The POCT used to diagnose sickle cell disease was HemoTypeSC. : Among the healthcare workers who participated in the study, 67% belonged to the scheduled tribes. When the ANM and LT competencies were compared for the pre-analytical phase (phase I), ANMs were more competent than the LTs. ANMs were more adept at handling people, whereas the LTs were more competent in conducting the test procedures. When the comparison was made for the analytical phase (phase II), both the ANMs and LTs were found to be equally competent. ANMs followed the standard operating procedure (SOP) more precisely than MOs and LTs. In the post-analytical phase, LTs were found to be more competent than ANMs. The approach used in this study with sub-centers and primary health centers (PHCs) appears to have encouraged the feasibility of the screening program. : The results of this study conclude that the healthcare workers in the region are competent to perform the POCT for the diagnosis of sickle cell disease. The POCT may be introduced in the program for the diagnosis of SCD.

摘要

印度的镰状细胞病(SCD)患者大多在出现症状时才被确诊。为了给参与者及时诊断SCD,医护人员应具备使用即时检验(POCT)的能力。在本研究中,我们旨在评估医护人员通过POCT筛查婴儿和成人人群的能力。

本研究于2023年4月至11月以试点模式进行了8个月。采用随机抽样方法选取了10名辅助护士助产士(ANM)、10名实验室技术员(LT)和5名医务人员(MO)。每个被选中的ANM和LT应进行10次检测,MO进行5次检测。用于诊断镰状细胞病的POCT是HemoTypeSC。

参与研究的医护人员中,67%属于在册部落。在分析前阶段(第一阶段)比较ANM和LT的能力时,ANM比LT更有能力。ANM更善于与人打交道,而LT在进行检测程序方面更有能力。在分析阶段(第二阶段)进行比较时,发现ANM和LT的能力相当。ANM比MO和LT更精确地遵循标准操作程序(SOP)。在分析后阶段,发现LT比ANM更有能力。本研究在分中心和初级卫生中心(PHC)采用的方法似乎促进了筛查项目的可行性。

本研究结果表明,该地区的医护人员有能力进行POCT以诊断镰状细胞病。POCT可引入SCD诊断项目中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e622/11817183/3a40b029bc2c/diagnostics-15-00348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e622/11817183/3a40b029bc2c/diagnostics-15-00348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e622/11817183/3a40b029bc2c/diagnostics-15-00348-g001.jpg

相似文献

1
Operational Feasibility of Point-of-Care Testing for Sickle Cell Disease in Resource-Limited Settings of Tribal Sub-Plan Region of India.印度部落次区域计划地区资源有限环境下镰状细胞病即时检测的操作可行性
Diagnostics (Basel). 2025 Feb 2;15(3):348. doi: 10.3390/diagnostics15030348.
2
Functioning and time utilisation by female multi-purpose health workers in South India: a time and motion study.印度南部女性多用途卫生工作者的工作功能和时间利用:一项时间和动作研究。
Hum Resour Health. 2018 Nov 26;16(1):64. doi: 10.1186/s12960-018-0327-3.
3
Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.强化卫生系统和社区动员,在印度部落人群中开展镰状细胞病筛查和管理:一项干预研究。
Hemoglobin. 2023 Nov;47(6):227-236. doi: 10.1080/03630269.2023.2300675. Epub 2024 Jan 22.
4
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India.印度部落地区通过初级卫生保健系统进行基于人群的镰状细胞病筛查的可行性。
J Med Screen. 2023 Mar;30(1):28-35. doi: 10.1177/09691413221123131. Epub 2022 Aug 28.
5
HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.用于镰状细胞病的低成本即时检测设备 HemoTypeSC:前景与挑战。
Blood Cells Mol Dis. 2019 Sep;78:22-28. doi: 10.1016/j.bcmd.2019.01.007. Epub 2019 Feb 8.
6
Barriers and facilitators to community acceptability of integrating point-of-care testing to screen for sickle cell disease in children in primary healthcare settings in rural Upper East Region of Northern Ghana.加纳上东部农村地区初级卫生保健机构中,以床边检测方式筛查儿童镰状细胞病的社区可接受性,其面临的障碍和促进因素。
PLoS One. 2024 May 20;19(5):e0303520. doi: 10.1371/journal.pone.0303520. eCollection 2024.
7
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.在尼日利亚将镰状细胞病新生儿筛查作为免疫规划的一部分实施:一项可行性研究。
Lancet Haematol. 2020 Jul;7(7):e534-e540. doi: 10.1016/S2352-3026(20)30143-5.
8
Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.冈比亚部分医疗机构针对镰状细胞病的即时检验新生儿筛查
Hemoglobin. 2024 May;48(3):169-174. doi: 10.1080/03630269.2024.2369523. Epub 2024 Jul 9.
9
Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.在资源匮乏环境中进行即时护理的镰状细胞病筛查:新型快速检测 HemoTypeSC 的多中心评估
Am J Hematol. 2019 Jan;94(1):39-45. doi: 10.1002/ajh.25305. Epub 2018 Oct 31.
10
HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes.HemoTypeSC即时检测在使用碱性醋酸纤维素血红蛋白电泳筛查血红蛋白SS和SC基因型时显示出高灵敏度。
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):341-345. doi: 10.1016/j.htct.2020.11.010. Epub 2021 Jan 27.

本文引用的文献

1
Burden of sickle cell disease in tribal students in institutions in southern Rajasthan - A pilot study.拉贾斯坦邦南部部落学生镰状细胞病负担-一项初步研究。
Indian J Med Res. 2022 Aug;156(2):269-274. doi: 10.4103/ijmr.ijmr_3195_21.
2
Feasibility Study of the "HemoTypeSC" Test for the Rapid Screening of Sickle Cell Disease in Côte D'Ivoire.“血液类型SC”检测在科特迪瓦快速筛查镰状细胞病的可行性研究
Adv Hematol. 2021 Mar 19;2021:8862039. doi: 10.1155/2021/8862039. eCollection 2021.
3
HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes.
HemoTypeSC即时检测在使用碱性醋酸纤维素血红蛋白电泳筛查血红蛋白SS和SC基因型时显示出高灵敏度。
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):341-345. doi: 10.1016/j.htct.2020.11.010. Epub 2021 Jan 27.
4
Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.尼日利亚拉各斯婴儿早期镰状细胞病筛查的可行性和可接受性:一项试点研究。
PLoS One. 2020 Dec 3;15(12):e0242861. doi: 10.1371/journal.pone.0242861. eCollection 2020.
5
Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.多中心评价 HemoTypeSC 作为一种即时检测新生儿和成人镰状细胞病的床边诊断测试在印度的应用。
Am J Clin Pathol. 2020 Jan 1;153(1):82-87. doi: 10.1093/ajcp/aqz108.
6
HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.用于镰状细胞病的低成本即时检测设备 HemoTypeSC:前景与挑战。
Blood Cells Mol Dis. 2019 Sep;78:22-28. doi: 10.1016/j.bcmd.2019.01.007. Epub 2019 Feb 8.
7
Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.在资源匮乏环境中进行即时护理的镰状细胞病筛查:新型快速检测 HemoTypeSC 的多中心评估
Am J Hematol. 2019 Jan;94(1):39-45. doi: 10.1002/ajh.25305. Epub 2018 Oct 31.
8
Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.印度东北部疟疾流行邦特里普拉邦血红蛋白病和红细胞酶病的新生儿筛查
Hemoglobin. 2018 Jan;42(1):43-46. doi: 10.1080/03630269.2018.1428619. Epub 2018 Feb 8.
9
A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.一种使用新型、高度特异性单克隆抗体的用于镰状细胞病的快速、廉价且一次性即时检测血液测试。
Br J Haematol. 2016 Nov;175(4):724-732. doi: 10.1111/bjh.14298. Epub 2016 Sep 8.
10
Validation of a novel point of care testing device for sickle cell disease.一种新型镰状细胞病即时检测设备的验证
BMC Med. 2015 Sep 16;13:225. doi: 10.1186/s12916-015-0473-6.